AzTrials
AzTrials

Antenatal DepressionNCT02366429

ICBT for Antenatal Depression

A study testing ICBT for antenatal depression and TAU in people with Antenatal Depression, run by Karolinska Institutet at 1 site in Sweden.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Randomized controlled trial evaluating an Internet-delivered Cognitive Behavioral Therapy (ICBT) adapted for pregnant women suffering from antenatal depression. The ICBT-program will be added to treatment as usual (TAU) and compared to TAU only. Read more about this study

Who is it for?
Ages 18 to 55 years, women only
Conditions the study is for
Antenatal Depression
What is being tested?
ICBT for antenatal depression and TAU
Could I receive a placebo?
No, everyone receives an active treatment
How many people
60 participants
Where
1 siteSweden
Study dates
Feb 2015to Mar 2016
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 55 years
  • Women only
  • No healthy volunteers
  • Adult

Who may be able to join

  • pregnant female > 18 years old at gestational week 11-28
  • verified moderate depression according to SCID-I with or without concomitant anxiety disorder
  • able to understand the Swedish language orally and in written
  • able to use the internet for the ICBT
  • currently in contact with an antenatal clinic to receive regular care

Who cannot join

  • known drug or alcohol abuse
  • serious somatic disorder or psychiatric disorder such as psychosis, bipolar disorder, severe personality disorder, autism or mental retardation and severe melancholic or psychotic depression,
  • having started or changed medication with SSRI, SNRI or mood-stabilizers within 3 weeks,
  • according to psychiatric assessment have a high suicide risk will be excluded from the study. These women will be helped to receive necessary psychiatric treatment as usual.

Trial locations and contacts

1 site in 1 country.

Sweden1 site
  • Internetpsykiatrienehten (Internet Psychiatry Unit), Psykiatri Sydväst, SLSO

    Stockholm

Other trials in Sweden

About this study

Official title: Psychological Treatment Via the Internet for Antenatal Depression

Randomized controlled trial evaluating an Internet-delivered Cognitive Behavioral Therapy (ICBT) adapted for pregnant women suffering from antenatal depression. The ICBT-program will be added to treatment as usual (TAU) and compared to TAU only.

Participants (n=60) are recruited from all over Sweden (only Swedish citizens can participate) and are assessed and treated on a distance via a secure web platform and telephone.

Read the detailed description

In order to evaluate feasibility and effectiveness of an ICBT-program for antenatal depression that will be used in a larger clinical trial, the current RCT (n=60) will be performed and act as a pilot for the main study.

Participants will all be receiving the regular treatment (TAU) provided at their antenatal clinic and other health care instances. Half of them will be randomized to an add-on of a previously established 10-week long ICBT-program for depression in general, now adapted for pregnant women. The other half will receive TAU during 10 weeks and then freely decide if they want to participate in the pregnancy-adapted ICBT-program (only possible if 10 or more weeks left till estimated delivery date), start the regular ICBT-program for depression within 2-6 weeks post-partum, or decline ICBT-treatment. The participants in this study will be recruited from all over Sweden via internet, advertisements and information at antenatal clinics. A web-based screening questionnaire will form the basis for a first assessment and review of inclusion criteria, followed by a structured telephone interview where diagnoses (SCID-1 for depression, adjusted for DSM 5, and M.I.N.I. for other diagnoses and assessment of suicide risk) and suitability will be assessed, a CGI-rating will be performed, and the final decision on inclusion will be made.

Level of depression pre- and post-treatment will be assessed with MADRS-S filled out via the internet-treatment platform together with the other self-rating measures used in the main study. A questionnaire where the participants evaluate the content of the adapted ICBT-program and their own use and perceived benefit of the treatment methods will also be given at post-treatment and during treatment.

Structured telephone interview will be held at post-treatment, primarily to assess the content of TAU, to administer CGI and a standardized version for MADRS-S (designed to replace missing questionnaire data), and to make a qualitative evaluation of the participants view of the adapted ICBT-program.

The estimated effect of ICBT compared to TAU is 0.8 (Cohen's d) and with 60 participants and some attrition this will result in a statistical power of 80% for this initial, smaller RCT.

Being tested
ICBT for antenatal depression, TAU

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • ICBT for antenatal depressionBehavioural

    Participants receives active therapist support via the internet to go through a 10-week self-help treatment on a secure web platform

  • TAUOther

    Treatment as usual provided at antenatal clinics and other health care instances

Study groups in NCT02366429
Study groupRoleWhat they receive
ICBTExperimentalInternet-based CBT for antenatal depression
Receives: Behavioral: ICBT for antenatal depression
TAUActive comparatorTreatment as usual provided at antenatal clinics and other health care instances
Receives: Other: TAU

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Self-rated depression measured by Montgomery Asberg Depression Rating Scale

    Depression measured by Montgomery Asberg Depression Rating Scale (MADRS-S), a 9-item self-rated measure of change in depression severity. It also screens for suicidality.

    Measured: Change from baseline to post-treatment (after 10 weeks) and to 3-4 weeks post-partum

Secondary outcomes (6)
  1. Self-rated antenatal depression Edinburgh Postnatal Depression Scale

    Edinburgh Postnatal Depression Scale (EPDS; Cox, Holden \& Sagovsky, 1987)

    Measured: Change from baseline to post-treatment (after 10 weeks) and to 3-4 weeks post-partum

  2. Self-rated function Work and Social Adjustment Scale

    Work and Social Adjustment Scale (WSAS; Zahra et al., 2014)

    Measured: Change from baseline to post-treatment (after 10 weeks) and to 3-4 weeks post-partum

  3. Self-rated Insomnia Insomnia Severity Index

    Insomnia Severity Index (ISI; Bastien, Vallieres \& Morin, 2001)

    Measured: Change from baseline to post-treatment (after 10 weeks) and to 3-4 weeks post-partum

  4. Self-rated function/quality of life Euroqol

    Euroqol (EQ-5D ; Hinz et al., 2006),

    Measured: Change from baseline to post-treatment (after 10 weeks) and to 3-4 weeks post-partum

  5. Self-rated anxiety and worry GAD-7

    GAD-7(Beard, \& Björgvinsson, 2014)

    Measured: Change from baseline to post-treatment (after 10 weeks) and to 3-4 weeks post-partum

  6. Expert rating of overall disease burden Clinical Global Impression - Severity scale

    Clinical Global Impression - Severity scale (CGI-S; Guy, 2000)

    Measured: Change from baseline to post-treatment (after 10 weeks) and to 3-4 weeks post-partum

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted19 Feb 2015 (estimated)
  2. Study startFeb 2015
  3. Primary completionMar 2016
  4. Study completionMar 2016

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
60 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02366429
Sponsor's protocol ID
20141959311
Status last verified
Sep 2016
First submitted
12 Feb 2015
Last updated
5 Sep 2016
Results posted
No
Data monitoring committee
No

Publications

  • Forsell E, Bendix M, Hollandare F, Szymanska von Schultz B, Nasiell J, Blomdahl-Wetterholm M, Eriksson C, Kvarned S, Lindau van der Linden J, Soderberg E, Jokinen J, Wide K, Kaldo V. Internet delivered cognitive behavior therapy for antenatal depression: A randomised controlled trial. J Affect Disord. 2017 Oct 15;221:56-64. doi: 10.1016/j.jad.2017.06.013. Epub 2017 Jun 13.

    PubMed 28628768

Questions about this trial

What is this clinical trial studying?

A study testing ICBT for antenatal depression and TAU in people with Antenatal Depression, run by Karolinska Institutet at 1 site in Sweden.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 5 Sep 2016. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Sweden. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Self-rated depression measured by Montgomery Asberg Depression Rating Scale (time frame: Change from baseline to post-treatment (after 10 weeks) and to 3-4 weeks post-partum). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT02366429, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 5 Sep 2016.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in